本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aclaris Therapeutics

1.58
+0.06003.95%
盘后1.57-0.0100-0.63%18:35 EDT
成交量:50.79万
成交额:79.01万
市值:1.71亿
市盈率:-1.09
高:1.58
开:1.54
低:1.51
收:1.52
数据加载中...
2022/01/14

重要事件披露

8-K - Current report
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/26

重要事件披露

8-K - Current report
2021/06/11

重要事件披露

8-K - Current report
2021/06/08

重要事件披露

8-K - Current report
2021/06/03

重要事件披露

8-K - Current report
2021/05/20

重要事件披露

8-K - Current report
2021/05/07

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/07

重要事件披露

8-K - Current report
2021/02/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals